Navigation Links
Study documents rapid increase in youth bipolar disorder diagnoses
Date:9/3/2007

CHICAGO The estimated number of youth with office visits with a diagnosis of bipolar disorder substantially increased between 1994 and 2003, while adult visits with a bipolar disorder diagnoses appeared to almost double, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Bipolar disorder is a psychiatric illness that typically involves periods of mania (an abnormally elevated mood) and depression. Although bipolar disorder may have its onset during childhood, little is known about national trends in the diagnosis and management of bipolar disorder in young people, the authors write as background information in the article.

Carmen Moreno, M.D., of the Hospital General Universitario Gregorio Maranon, Servicio de Psiquiatria, Madrid, Spain, and colleagues analyzed data from a national survey of office-based physicians designed to represent all such clinicians in the United States. The physicians provided information about demographic, clinical and treatment aspects of each patient visit for a one-week time period. The researchers compared the rate of growth in bipolar disorder diagnoses among individuals age 19 and under to that of individuals age 20 and older from 1994 to 1995 through 2002 to 2003. They also compared demographic information and prescribed treatments between the two groups during the years 1999 to 2003.

The annual number of office-based visits with a diagnosis of bipolar disorder in youth was estimated to increase from 25 per 100,000 youth in 1994 to 1995 to 1,003 per 100,000 youth in 2002 to 2003. In the same time, outpatient visits with a diagnosis of bipolar disorder in adults increased from 905 to 1,679 per 100,000 population. As a percentage of total office-based visits, visits with a diagnosis of bipolar disorder increased among youth from 0.01 percent (1994 to 1995) to 0.44 percent (2002 to 2003), and among adults, from 0.31 percent to 0.5 percent in the same time periods.

Between 1999 and 2003, most young people diagnosed with bipolar disorder were male (66.5 percent), while 67.6 percent of diagnosed adults were females. Young people were more likely than adults to receive diagnoses of both bipolar disorder and attention-deficit/hyperactivity disorder (32.2 percent vs. 3 percent).

The impressive increase in the diagnosis of childhood and adolescent bipolar disorder in U.S. office-based practice indicates a shift in clinical diagnostic practices, the authors write. In broad terms, either bipolar disorder was historically underdiagnosed in children and adolescents and that problem has now been rectified, or bipolar disorder is currently being overdiagnosed in this age group. Without independent systematic diagnostic assessments, we cannot confidently select between these two competing hypotheses.

Most youth (90.6 percent) and adults (86.4 percent) were prescribed medications to treat bipolar disorder, including mood stabilizers, antipsychotics and antidepressants. These similarities occurred despite the fact that the condition and treatments may affect adults and children differently, the authors note. There is an urgent need to study the reliability and validity using multiple informant strategies of the diagnosis of child and adolescent bipolar disorder in community practice and to evaluate the effectiveness and safety of pharmacological treatment regimens commonly used to treat youth diagnosed with bipolar disorder, they conclude.


'/>"/>

Contact: Dacia Morris
212-543-5421
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. Gene study links endometriosis, infertility
2. Study reveals how stress can make you sick
3. Study points out that HIV vaccine may not be accepted easily
4. A new study surpasses Gene Therapy Hurdle
5. Tomato Sauce reduces Cancer Risk- Study
6. A question on study of Adult Stem Cell
7. Study on obesity and heart failure
8. National Lung Study in the process
9. Marijuana gateway theory strengthened by study of twins
10. Old theory of adaptation confirmed by new study
11. Study casts doubt on keyboard ills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... ... today that nominations will be accepted February 8, 2016 through May 8, ... Awards include the Information Security Executive® of the Year, which recognizes executives ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with ... time to make a change in public health,” states Carole Baggerly, Director of ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now ... country. The AutismOne 2016 Conference, which is being held May 25-29 at the Loews ... elsewhere about helpful interventions and causes of chronic illness in children. , Very recent ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... has added Kybella® to his medical and surgical expertise. Technically known as deoxycholic ... injectable medication used as a non-surgical alternative for reduction of fat below the ...
(Date:2/6/2016)... Pekin, IL (PRWEB) , ... February 06, 2016 ... ... the recovery phases of eating disorder treatment helps to reduce the frequency and ... “Tasks of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb.8, 2016 Aesthetic Devices - ... Medical Devices sector report, "Aesthetic Devices - Medical Devices ... currently in pipeline stage. This report ... and primary research by GlobalData,s team of industry experts. ... removed or altered based on the availability and relevance ...
(Date:2/8/2016)... SAN DIEGO , Feb. 8, 2016  Neurocrine ... the Company will report its fourth quarter and year-end ...  February 11, 2016.  Neurocrine will then host a live ... and provide a Company update Thursday afternoon, February 11, ... Time). http://www.neurocrine.com . --> http://www.neurocrine.com ...
(Date:2/8/2016)... N.J. , Feb. 8, 2016   GS1 ... healthcare professionals to guide them through GS1 Standards implementation ... Drug Administration (FDA) Unique Device Identification (UDI) rule. ... GS1 US; Beth Gibson , senior director industry ... , industry development director, GS1 US --> ...
Breaking Medicine Technology: